ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
NeuroRx Announces ZYESAMI Trial Met Primary Endpoint
March 30, 2021NeuroRx reports 60-day results of the Phase 2b/3 trial of intravenously-administered ZYESAMI™ (aviptadil acetate) for the treatment of respiratory failure in critically-ill patients with COVID-19, which is being developed in collaboration with ... -
SignPath, Relief explore drugs for Covid-19-related ARDS
March 19, 2020SignPath Pharma has begun efforts to develop Lipocurc, an intravenous liposomal curcumin formulation, to treat acute respiratory distress syndrome (ARDS) caused by Covid-19. -
A 5-Minute Recipe for Stress Relief
June 05, 2019A 5-Minute Recipe for Stress Relief.
Pharma Sources Insight January 2025
